You have full text access to this OnlineOpen article

Cancer

Cover image for Cancer

15 July 2000

Volume 89, Issue 2

Pages 229–473

  1. Listen to the Patient

    1. Top of page
    2. Listen to the Patient
    3. Editorials
    4. Commentary
    5. Original Articles
    6. Erratum
    1. You have free access to this content
      It frightens me. It's personal. Hurry. (pages 229–230)

      Gerald F. Humphreys

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<229::AID-CNCR1>3.0.CO;2-C

      This essay is the second in a series of essays by cancer patients. Perceptions of two individuals, a patient and a doctor, are detailed in the present article. Readers are encouraged to share their thoughts about these essays in correspondence.

    2. You have free access to this content
      A physician's point of view (pages 230–231)

      B. J. Kennedy

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<230::AID-CNCR2>3.0.CO;2-F

      This essay is the second in a series of essays by cancer patients. Perceptions of two individuals, a patient and a doctor, are detailed in the present article. Readers are encouraged to share their thoughts about these essays in correspondence.

  2. Editorials

    1. Top of page
    2. Listen to the Patient
    3. Editorials
    4. Commentary
    5. Original Articles
    6. Erratum
    1. Counterpoint

      You have full text access to this OnlineOpen article
      Caveats for modeling disease free survival after radical prostatectomy (pages 232–233)

      John T. Wei and James E. Montie

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<232::AID-CNCR3>3.0.CO;2-A

      There is a trend toward the greater application of statistical modeling to prognosticate the outcome of patients with prostate carcinoma. Although these techniques are powerful research tools, the clinician should keep in mind the limitations of applying such findings to their own practice.

      See also pages 234–5 and 404–11.

    2. Reply to Counterpoint

      You have full text access to this OnlineOpen article
      Caveats for modeling disease free survival after radical prostatectomy : Reply (pages 234–235)

      Mousumi Banerjee

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<234::AID-CNCR4>3.0.CO;2-5

      See also pages 232–3 and 404–11.

  3. Commentary

    1. Top of page
    2. Listen to the Patient
    3. Editorials
    4. Commentary
    5. Original Articles
    6. Erratum
    1. You have full text access to this OnlineOpen article
      The Augsburg consensus : Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies (pages 236–241)

      Alistair J. Cochran, Bernd-Rüdiger Balda, Hans Starz, Dieter Bachter, David N. Krag, C. Wayne Cruse, Rik Pijpers and Donald L. Morton

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<236::AID-CNCR5>3.0.CO;2-0

      Sentinel lymph node surgery is increasingly used in the management of cutaneous malignancies. This commentary indicates the surgical, pathologic, and nuclear medicine techniques necessary for success.

  4. Original Articles

    1. Top of page
    2. Listen to the Patient
    3. Editorials
    4. Commentary
    5. Original Articles
    6. Erratum
    1. Anatomic Site

      You have full text access to this OnlineOpen article
      A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma (pages 242–247)

      Ming-Huang Hong, Hai-Qiang Mai, Hua-Qing Min, Jun Ma, En-Pi Zhang and Nian-Ji Cui

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<242::AID-CNCR6>3.0.CO;2-Z

      The 5-year survival rates for patients in the corresponding stages of the Chinese 1992 and fifth-edition International Union Against Cancer (UICC) systems are almost identical in spite of differences in criteria defining the T and N classifications. However, the authors of this study believe that the UICC system is slightly better.

    2. You have full text access to this OnlineOpen article
      Significance of involvement by squamous cell carcinoma of the ducts of esophageal submucosal glands : Analysis of 201 surgically resected superficial squamous cell carcinomas (pages 248–254)

      Yusuke Tajima, Yukihiro Nakanishi, Yuji Tachimori, Hoichi Kato, Hiroshi Watanabe, Hajime Yamaguchi, Kimio Yoshimura, Mitsuo Kusano and Tadakazu Shimoda

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<248::AID-CNCR7>3.0.CO;2-Q

      The results of this study indicate that mucosal carcinomas with ductal involvement (DI) that extends to the submucosa should not be classified as submucosal carcinoma. However, when removed by endoscopic mucosal resection, tumors require careful examination to allow possible detection of DI in the resected specimen, i.e., to ensure complete tumor resection.

    3. You have full text access to this OnlineOpen article
      Early and late recurrence after gastrectomy for gastric carcinoma : Univariate and multivariate analyses (pages 255–261)

      Norio Shiraishi, Masafumi Inomata, Naofumi Osawa, Kazuhiro Yasuda, Yosuke Adachi and Seigo Kitano

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<255::AID-CNCR8>3.0.CO;2-N

      Multivariate analysis of 138 patients who died of recurrence after gastrectomy for gastric carcinoma indicated that the stage of disease or level of lymph node metastasis was an independent factor associated with the survival time. Patients with more advanced stage of disease or those with extended lymph node metastasis frequently died of recurrence within 2 years after gastrectomy.

    4. You have full text access to this OnlineOpen article
      Modulation of tumor-induced lethality after pneumoperitoneum in a mouse model (pages 262–266)

      Joachim Volz, Stefanie Volz-Köster, Simone Kanis, Daniela Klee, Christiane Ahlert and Frank Melchert

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<262::AID-CNCR9>3.0.CO;2-K

      The induction of a pneumoperitoneum decreases survival time by increasing tumor cell growth and decreases the efficacy of intraperitoneal chemotherapy. This effect appears to be reduced by the intraperitoneal use of heparin/taurolidine.

    5. You have full text access to this OnlineOpen article
      Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma : Clinicopathologic study of 152 first resection cases (pages 267–275)

      Keiichi Okano, Junji Yamamoto, Tomoo Kosuge, Seiichiro Yamamoto, Michiie Sakamoto, Yukihiro Nakanishi and Setsuo Hirohashi

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<267::AID-CNCR10>3.0.CO;2-1

      The presence of fibrous tissue between tumor and the surrounding hepatic parenchyma was noted in 93 of 152 patients (61%) who underwent hepatectomy for colorectal liver metastases. Clinicopathologically, the presence of such a fibrous pseudocapsule in patients with colorectal liver metastases was correlated with less invasiveness of the disease to adjacent vessels and a good prognosis after resection compared with patients without such a capsule.

    6. You have full text access to this OnlineOpen article
      Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma (pages 276–284)

      Takashi Shibata, Takahiro Niinobu, Norio Ogata and Motohisa Takami

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<276::AID-CNCR11>3.0.CO;2-0

      In this study, the therapeutic efficacy of microwave coagulation in the treatment of hepatic metastases from colorectal carcinoma was compared with that of hepatic resection. It is suggested that microwave coagulation is equally effective as hepatic resection in terms of a survival rate, whereas the surgical invasiveness of this technique is less than that of hepatic resection.

    7. You have full text access to this OnlineOpen article
      Distribution of colorectal liver metastases in patients referred for hepatic resection (pages 285–287)

      Stephen J. Wigmore, Krishnakumar Madhavan, Doris N. Redhead, Elspeth J. Currie and O. James Garden

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<285::AID-CNCR12>3.0.CO;2-#

      This study examined whether the site of a primary colon carcinoma would influence the anatomic distribution of metastases within the liver. No significant difference in seeding of metastases to the right or left hemiliver could be identified when patients who had right- or left-sided colorectal carcinoma were compared.

    8. You have full text access to this OnlineOpen article
      Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy (pages 288–296)

      Karl H. Link, Marko Kornmann, Urwe Butzer, Gerd Leder, Ellen Sunelaitis, Jürgen Pillasch, Dennis Salonga, Kathleen D. Danenberg, Peter V. Danenberg and Hans G. Beger

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<288::AID-CNCR13>3.0.CO;2-O

      The responses and survival of patients with isolated, nonresectable liver tumors who receive regional hepatic arterial infusion chemotherapy may be predictable with thymidylate synthase quantitation and in vitro chemosensitivity testing.

    9. You have full text access to this OnlineOpen article
      Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients (pages 297–302)

      Mario Pirisi, Pierluigi Toniutto, Alessandro Uzzau, Carlo Fabris, Claudio Avellini, Cathryn Scott, Luca Apollonio, Carlo A. Beltrami and Fabrizio Bresadola

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<297::AID-CNCR14>3.0.CO;2-N

      Heterozygotes for missense mutations in the HFE gene are overrepresented among patients with hepatocellular carcinoma undergoing surgical resection; these patients may represent a cirrhotic subgroup with reduced survival for whom surgical resection of the tumor might not be the best treatment option.

    10. You have full text access to this OnlineOpen article
      A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization (pages 303–313)

      Hisato Homma, Tadashi Doi, Shinichi Mezawa, Kohichi Takada, Takehiro Kukitsu, Takaomi Oku, Takehide Akiyama, Toshiro Kusakabe, Koji Miyanishi and Yoshiro Niitsu

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<303::AID-CNCR15>3.0.CO;2-1

      In patients with advanced pancreatic carcinoma, arterial infusion chemotherapy after vascular supply distribution via superselective embolization was effective against both primary tumors and metastatic liver lesions.

    11. You have full text access to this OnlineOpen article
      Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma : An outcomes trial (pages 314–327)

      Harry Snady, Howard Bruckner, Avram Cooperman, Jana Paradiso and Laurel Kiefer

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<314::AID-CNCR16>3.0.CO;2-V

      Chemoradiotherapy followed by resection, when possible, is associated with less early mortality and appears to increase survival from the time of diagnosis for patients with pancreatic tumors reliably staged as unresectable. Preoperative chemotherapy and/or radiotherapy for earlier resectable stages of pancreatic carcinoma require further investigation.

    12. You have full text access to this OnlineOpen article
      Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial (pages 328–333)

      John D. Hainsworth, Howard A. Burris III, Sharlene Litchy, Lisa H. Morrissey, John H. Barton, James E. Bradof and F. Anthony Greco

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<328::AID-CNCR17>3.0.CO;2-F

      Thirty-nine elderly or poor performance status patients with advanced, previously untreated nonsmall cell lung carcinoma received weekly treatment with docetaxel. Treatment was well tolerated, resulted in minimal myelosuppression, and produced a response rate of 18% with a 1-year survival rate of 27%.

    13. You have full text access to this OnlineOpen article
      Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung (pages 334–341)

      Akira Kamimura, Masafumi Kamachi, Jun Nishihira, Shigeaki Ogura, Hiroshi Isobe, Hirotoshi Dosaka-Akita, Akihiko Ogata, Masanobu Shindoh, Toshiro Ohbuchi and Yoshikazu Kawakami

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N

      Macrophage migration inhibitory factor (MIF) is highly expressed in both the cytoplasm and nucleus of lung adenocarcinoma cells. Decreased MIF expression in the nuclei is correlated significantly with poor prognosis in patients with lung adenocarcinoma.

    14. You have full text access to this OnlineOpen article
      Patterns of detection in patients with cutaneous melanoma : Implications for secondary prevention (pages 342–347)

      Mary S. Brady, Susan A. Oliveria, Paul J. Christos, Marianne Berwick, Daniel G. Coit, Jared Katz and Allan C. Halpern

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<342::AID-CNCR19>3.0.CO;2-P

      Physician detection and family history are associated with presentation in patients with early melanoma.

    15. You have full text access to this OnlineOpen article
      Trends in mortality from malignant melanoma in Sweden, 1970–1996 (pages 348–355)

      Gabriella Cohn-Cedermark, Eva Månsson-Brahme, Lars Erik Rutqvist, Olle Larsson, Hemming Johansson and Ulrik Ringborg

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<348::AID-CNCR20>3.0.CO;2-X

      Melanoma mortality in Sweden has leveled off since the mid-1980s. During the period 1987–1996, a statistically significant downward trend was observed for females. Educational campaigns may have contributed to these trends.

    16. You have full text access to this OnlineOpen article
      Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes : Gabapentin may serve as a mood stabilizer (pages 356–362)

      Donna B. Greenberg, Eric Jonasch, Michele A. Gadd, Bonita F. Ryan, James R. Everett, Arthur J. Sober, Martin A. Mihm, Kenneth K. Tanabe, Mark Ott and Frank G. Haluska

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<356::AID-CNCR21>3.0.CO;2-Z

      Mania and mood instability are underdiagnosed side effects of adjuvant interferon therapy for melanoma patients. Recognition and treatment of these syndromes has the potential to improve quality of life in this patient population.

    17. You have full text access to this OnlineOpen article
      Predictors of skeletal complications in patients with metastatic breast carcinoma (pages 363–368)

      Susan M. Domchek, Jerry Younger, Dianne M. Finkelstein and Michael V. Seiden

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<363::AID-CNCR22>3.0.CO;2-3

      Skeletal complications in women with metastatic breast carcinoma are extremely common, frequently occur multiple times in a single patient, and predate patient death by 1 year or more in women with any bone disease at the time of presentation of metastatic disease. Bone involvement at the time of initial presentation of metastatic disease was found to be the sole independent predictor of skeletal complications on multivariate analysis.

    18. You have full text access to this OnlineOpen article
      The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont (pages 369–375)

      Prudence B. Lam, Pamela M. Vacek, Berta M. Geller and Hyman B. Muss

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<369::AID-CNCR23>3.0.CO;2-J

      Among postmenopausal women, increased weight or body mass index and mammographically dense breast tissue are significant independent breast carcinoma risk factors. Overweight women with dense breasts may be at particularly high risk.

    19. You have full text access to this OnlineOpen article
      Case-control study of plasma folate, homocysteine, vitamin B12, and cysteine as markers of cervical dysplasia (pages 376–382)

      Marc T. Goodman, Katharine McDuffie, Brenda Hernandez, Lynne R. Wilkens and Jacob Selhub

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<376::AID-CNCR24>3.0.CO;2-O

      This case-control study does not appear to support the hypothesis that folate, homocysteine, or B12 are markers of risk for cervical dysplasia. A possible inverse association between plasma cysteine concentrations and the risk of cervical dysplasia is suggested.

    20. You have full text access to this OnlineOpen article
      Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes (pages 383–390)

      Richard R. Barakat, Mark G. Federici, Patricia E. Saigo, Mark E. Robson, Kenneth Offit and Jeff Boyd

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T

      Ovarian tissues removed prophylactically from women with germline mutations of BRCA1 were compared with ovarian tissues from control subjects for the frequency of premalignant morphologic alterations and alterations in molecular and cell biologic markers associated with ovarian tumorigenesis. No differences were observed between the two groups with regard to any of these features, indicating that premalignant alterations in ovaries from BRCA1 heterozygotes are rare.

    21. You have full text access to this OnlineOpen article
      Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors : A review of 74 cases (pages 391–398)

      Jeffrey J. H. Low, Lewis C. Perrin, Alex J. Crandon and Neville F. Hacker

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<391::AID-CNCR26>3.0.CO;2-V

      Advanced disease in young patients with malignant ovarian germ cell tumors should not necessarily contraindicate conservative surgery. The majority of these patients who have received combination chemotherapy resume normal ovarian function and can expect a normal fertility rate and healthy offspring.

    22. You have full text access to this OnlineOpen article
      External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma : Results of long term follow-up (pages 399–403)

      Özer Algan, Helen Fosmire, K. Hynynen, Bruce Dalkin, Haitan Cui, George Drach, Baldassarre Stea and James R. Cassady

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<399::AID-CNCR27>3.0.CO;2-4

      The purpose of the current study was to demonstrate treatment outcome and the long term treatment toxicity in patients treated with hyperthermia and external beam radiation therapy for locally advanced prostate carcinoma. Overall, both the pretreatment prostate specific antigen (PSA) level and the PSA nadir reached were statistically significant for biochemical no evidence of disease status, whereas the duration of hyperthermia showed a trend toward significance for overall survival. No patients were reported to develop long term morbidity from the addition of the hyperthermia therapy.

    23. You have full text access to this OnlineOpen article
      Recursive partitioning for prognostic grouping of patients with clinically localized prostate carcinoma (pages 404–411)

      Mousumi Banerjee, Debjit Biswas, Wael Sakr and David P. Wood Jr.

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<404::AID-CNCR28>3.0.CO;2-M

      The current article provides prognostic groupings of patients undergoing radical prostatectomy for clinically localized prostate carcinoma. Results of analyses based on recursive partitioning and amalgamation are valuable not just for making prognostic statements but also for use in clinical trial design for efficacy testing of adjuvant therapies.

      See also pages 232–3 and 234–5.

    24. You have full text access to this OnlineOpen article
      Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma (pages 412–423)

      Paul J. Birckbichler, Rebecca B. Bonner, Robert E. Hurst, Barbara L. Bane, Jan V. Pitha and George P. Hemstreet III

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<412::AID-CNCR29>3.0.CO;2-O

      High sensitivity and specificity of transglutaminase may provide a useful adjunct to pathology in benign prostate biopsies.

    25. You have full text access to this OnlineOpen article
      Surgical and postoperative factors affecting length of hospital stay after radical prostatectomy (pages 424–430)

      Thomas A. Gardner, Eric A. Bissonette, Gina R. Petroni, Rebecca McClain, Mitchell H. Sokoloff and Dan Theodorescu

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<424::AID-CNCR30>3.0.CO;2-6

      Length of hospital stay is one of the main contributors to the cost associated with radical prostatectomy for localized prostate carcinoma. The authors present a comprehensive analysis of factors contributing to the length of hospital stay after radical prostatectomy that they believe demonstrates that the impact of such factors is highly dependent on the surgical approach chosen for radical prostatectomy.

    26. You have full text access to this OnlineOpen article
      Weekly 1-hour infusion of paclitaxel : Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma (pages 431–436)

      Charu Trivedi, Bruce Redman, Lawrence E. Flaherty, Omer Kucuk, Wei Du, Lance K. Heilbrun and Maha Hussain

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<431::AID-CNCR31>3.0.CO;2-B

      Paclitaxel at a dose of 150 mg/m2 weekly for 6 weeks every 8 weeks has clinical activity in patients with hormone-refractory prostate carcinoma. Peripheral neuropathy is the major toxicity of this regimen.

    27. You have full text access to this OnlineOpen article
      Survival from head and neck cancer in Mumbai (Bombay), India (pages 437–444)

      Balakrishna B. Yeole, Rengaswamy Sankaranarayanan, Lizzy Sunny, R. Swaminathan and D. M. Parkin

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<437::AID-CNCR32>3.0.CO;2-R

      Survival analysis of 6311 incident head and neck cancer patients in the Bombay population during the years 1987–1991 revealed a 5-year relative survival rate of 36.7% and survival ranging from 25.5% to 74.5% for component subsites. Though early detection linked with adequate local treatment can further improve prognosis for patients with head and neck cancer, primary prevention by tobacco and alcohol control is an important long term measure.

    28. You have full text access to this OnlineOpen article
      Telomerase activity in B-cell non-Hodgkin lymphoma (pages 445–452)

      Scott A. Ely, Amy Chadburn, C. Mitchell Dayton, Ethel Cesarman and Daniel M. Knowles

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<445::AID-CNCR33>3.0.CO;2-T

      Telomerase activity is found at varying levels in all types of B-cell non-Hodgkin lymphoma, except for low grade marginal zone lymphomas, including mucosa-associated lymphoid tissue types. However, it is not constitutively active and appears to be under proliferative control.

    29. You have full text access to this OnlineOpen article
      Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma (pages 453–462)

      Jeffrey D. Wagner, Michael S. Gordon, Tsu-Yi Chuang, John J. Coleman III, John T. Hayes, Sin-Ho Jung and Charlene Love

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<453::AID-CNCR34>3.0.CO;2-V

      Increasing tumor thickness, ulceration, and a high mitotic index are useful predictors of sentinel lymph node biopsy results in patients with melanoma, but these variables do not appear to predict the presence of residual disease in the lymph node basin after a positive sentinel lymph node biopsy.

    30. General Topic

      Pediatric Oncology
      You have full text access to this OnlineOpen article
      Epstein–Barr virus infection in salivary gland tumors in children and young adults (pages 463–466)

      Lakshmi Venkateswaran, Yan-jun Gan, John W. Sixbey and Victor M. Santana

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<463::AID-CNCR35>3.0.CO;2-R

      It is unlikely that Epstein–Barr virus infection plays a major role in the pathogenesis of common salivary gland tumors in children.

    31. Posttransplantation Lymphoproliferative Disorders
      You have full text access to this OnlineOpen article
      Posttransplant Epstein–Barr virus–associated myogenic tumors involving bone : A case report (pages 467–472)

      Ka Fai To, Fernand M. M. Lai, Angela Y. M. Wang, Chi Bon Leung, Paul C. L. Choi, Cheuk Chun Szeto, Sui Fai Lui, Alex W. Y. Yu and Philip Kam Tao Li

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<467::AID-CNCR36>3.0.CO;2-C

      This report described the first case of posttransplant Epstein–Barr virus–associated smooth muscle tumor involving bone, which is also distinguished by its symmetric distribution at presentation. In this study, a delicate equilibrium in immunomodulation has been maintained for 8 years to preserve a functioning renal allograft and to control tumor growth.

  5. Erratum

    1. Top of page
    2. Listen to the Patient
    3. Editorials
    4. Commentary
    5. Original Articles
    6. Erratum
    1. You have free access to this content
      Erratum (page 473)

      Article first published online: 13 NOV 2000 | DOI: 10.1002/1097-0142(20000715)89:2<473::AID-CNCR37>3.0.CO;2-K

SEARCH

SEARCH BY CITATION